News

April 2010

Sentinel Oncology are pleased to announce that they have recently been awarded a development grant from the East of England… read more

March 2010

Sentinel Oncology is pleased to announce that its FLT3 kinase programme is available for partnering. Mutations in the… read more

March 2010

Sentinel Oncology will be attending BIO 2010 in Chicago (3rd-6th May) and will be available for partnering discussions throughout… read more

May 2009

Sentinel Oncology will be attending BIO Atlanta (18th-21st May 2009) and available for partnering discussions. Contact us… read more

February 2009

Sentinel Oncology, the Cambridge based cancer company focused on the discovery of novel treatments… read more

January 2009

Sentinel Oncology is pleased to announce the appointment of Dr. John Dixon to the board of Directors.… read more

December 2008

“Sentinel Oncology is delighted to be recognised by ERBI in receipt of this award for innovation in drug discovery“said… read more

October 2008

Sentinel Oncology will be attending Biopartnering Europe at the QEII conference centre in London on 13-14th October. Why… read more

January 2008

Sentinel Oncology announce that their Checkpoint kinase 1 programme is available for pre-clinical partnering. To arrange… read more

October 2007

Sentinel Oncology Ltd secures £1.3M investment from Wellcome Trust to develop innovative cancer drugs. Funds will… read more

Events

15th April 2010
Anglo Nordic Biotech conference
London, UK

3rd-6th May 2010
BIO International Convention
Chicago, IL, USA

4th-8th June 2010
ASCO
Chicago, IL, USA

10th-12th October 2010
BPE
London, UK

9th December 2010
Genesis conference
London, UK